264 related articles for article (PubMed ID: 20411798)
1. HIV-associated Kaposi sarcoma in African children.
Feller L; Khammissa RA; Gugushe TS; Chikte UM; Wood NH; Meyerov R; Lemmer J
SADJ; 2010 Feb; 65(1):20-2. PubMed ID: 20411798
[TBL] [Abstract][Full Text] [Related]
2. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
3. AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.
Sissolak G; Mayaud P
Trop Med Int Health; 2005 Oct; 10(10):981-92. PubMed ID: 16185232
[TBL] [Abstract][Full Text] [Related]
4. Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology.
Pfeiffer RM; Wheeler WA; Mbisa G; Whitby D; Goedert JJ; de Thé G; Mbulaiteye SM
Ann Epidemiol; 2010 Dec; 20(12):958-63. PubMed ID: 21074111
[TBL] [Abstract][Full Text] [Related]
5. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma.
Simonart T
Cancer Lett; 2006 Nov; 244(1):1-7. PubMed ID: 16542773
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCR.
Albrecht D; Meyer T; Lorenzen T; Stoehr A; Arndt R; Plettenberg A
J Clin Virol; 2004 Jun; 30(2):145-9. PubMed ID: 15125870
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
9. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
10. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
Nuwaha F
East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
[TBL] [Abstract][Full Text] [Related]
11. HHV-8 infection in African children.
Sarmati L
Herpes; 2004 Aug; 11(2):50-3. PubMed ID: 15955270
[TBL] [Abstract][Full Text] [Related]
12. HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence.
Wamburu G; Masenga EJ; Moshi EZ; Schmid-Grendelmeier P; Kempf W; Orfanos CE
Eur J Dermatol; 2006; 16(6):677-82. PubMed ID: 17229611
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.
Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U
Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
15. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
Ariyoshi K; Schim van der Loeff M; Cook P; Whitby D; Corrah T; Jaffar S; Cham F; Sabally S; O'Donovan D; Weiss RA; Schulz TF; Whittle H
J Hum Virol; 1998; 1(3):193-9. PubMed ID: 10195242
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
[TBL] [Abstract][Full Text] [Related]
18. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa.
Kasolo FC; Mpabalwani E; Gompels UA
J Gen Virol; 1997 Apr; 78 ( Pt 4)():847-55. PubMed ID: 9129658
[TBL] [Abstract][Full Text] [Related]
19. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
